Viewing StudyNCT05732454



Ignite Creation Date: 2024-05-06 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05732454
Status: TERMINATED
Last Update Posted: 2024-05-22
First Post: 2022-12-22

Brief Title: A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis AD Who Have Already Tried Treatments Taken by Mouth or by Injection
Sponsor: Pfizer
Organization: Pfizer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-01-18
Start Date Type: ACTUAL
Primary Completion Date: 2024-04-29
Primary Completion Date Type: ACTUAL
Completion Date: 2024-04-29
Completion Date Type: ACTUAL
First Submit Date: 2022-12-22
First Submit QC Date: February 7 2023
Study First Post Date: 2023-02-17
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-21
Last Update Post Date: 2024-05-22
Last Update Post Date Type: ACTUAL